In India, the Russian-developed Corona Vaccine Sputnik V has been approved for emergency use. This is the third vaccine for the coronavirus to be approved after Kovshield (Serum Institute of India) and Kovaxin (Bharat Biotech).
The Sputnik V vaccine, developed by Moscow's Gamale National Research Institute of Epidemiology and Microbiology, uses two different viruses that cause the common cold (adenovirus) in humans. Adenovirus becomes weak so it cannot replicate in humans and cannot cause disease.
Let me tell you that this vaccine is also modified. For this reason, the vaccine provides a code for making the coronavirus spike protein. The purpose of this process is to ensure that when the actual virus tries to infect the body, it can mount an immune response in the form of antibodies.
Sputnik uses a different vector for each of the two shots during vaccination. According to this Russian Direct Investment Fund (RDIF), the same methods are used for both shots. It provides immunity with a longer duration than other vaccines. A difference of 21 days is required for both shots.
Sputnik V (liquid) is stored at a temperature of minus 18 ° C. However, its dried form can be stored at 2–8 ° C. This does not require investing in cold-chain infrastructure. According to the RDIF, Sputnik V has been approved for the use of more than 150 crore people in 55 countries. The vaccine is proposed to be priced below $ 10 per shot. Although its price in India has not been decided.
Dr. Reddy's labs based in Hyderabad sought government approval for the vaccine in India. RDIF partnered with Dr. Reddy's in September 2020 to conduct clinical trials in the country. On Monday, the Subject Expert Committee (SEC) of the Drugs Controller General of India took the Sputnik V application for Emergency Use Authority and moved on. DCGI previously sought additional data from the drug manufacturer.
Five other Indian companies have partnered with RDIF for Sputnik V. These include Gland Pharma, Hetero Biopharma, Virchow Biotech, Panacea Biotech, and Stellis Biopharma, Bangalore-based Strides Pharma Science's bioceramic. It is expected from their partnerships that India's capacity to manufacture this vaccine will exceed 60 million.
External Affairs Minister S. Jaishankar has questioned the US sanctioning $450 million (Rs 3,651
The strong steps taken by the Modi government in Jammu and Kashmir have started showing their eff
China strongest of America's enemies, we need to be held accountable: Nikki Haley
Indian-origin Nikki Haley, who is contesting the presidential election, said that China is the st
The love story of Eden Gardens and Rohit Sharma had started when Rohit was in the early stages of
Karthik Aryan is in the news these days for his much-awaited film Chandu Champion. Mean
Salman Khan Firing Case More new revelations have been made in the firing case at Bollywood super
In the eliminator match of the Women's Premier League, RCB entered the final with a win against M
Prime Minister Narendra Modi will be on a three-day visit to Gujarat from Saturday. He will chair
Lakhs of drivers of Delhi-NCR have suffered a triple blow of inflation on Monday. While oil marke
The 8th International Yoga Day is being celebrated all over the world including India today. PM M
